These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12943462)

  • 1. Pharmacogenomics, genetic testing and ethnic variability: tackling the ethical questions.
    Winkelmann BR
    Pharmacogenomics; 2003 Sep; 4(5):531-5. PubMed ID: 12943462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the LURIC study--a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease.
    Winkelmann BR; März W; Boehm BO; Zotz R; Hager J; Hellstern P; Senges J;
    Pharmacogenomics; 2001 Feb; 2(1 Suppl 1):S1-73. PubMed ID: 11258203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics and large scale phenotypic databases.
    Winkelmann BR
    Pharmacogenomics; 2001 Feb; 2(1):3-5. PubMed ID: 11258195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers.
    Siest G; Marteau JB; Maumus S; Berrahmoune H; Jeannesson E; Samara A; Batt AM; Visvikis-Siest S
    Eur J Pharmacol; 2005 Dec; 527(1-3):1-22. PubMed ID: 16316654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenomics: questions and concerns.
    Mahlknecht U; Voelter-Mahlknecht S
    Curr Med Res Opin; 2005 Jul; 21(7):1041-7. PubMed ID: 16004671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New paradigms in cardiovascular medicine: emerging technologies and practices: perioperative genomics.
    Podgoreanu MV; Schwinn DA
    J Am Coll Cardiol; 2005 Dec; 46(11):1965-77. PubMed ID: 16325027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospects of personalized medicine in cardiovascular diseases.
    Lenfant C
    Metabolism; 2013 Jan; 62 Suppl 1():S6-10. PubMed ID: 22999711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primer on medical genomics. Part VI: Genomics and molecular genetics in clinical practice.
    Ansell SM; Ackerman MJ; Black JL; Roberts LR; Tefferi A
    Mayo Clin Proc; 2003 Mar; 78(3):307-17. PubMed ID: 12630584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human genome project: pharmacogenomics and drug development.
    Ganguly NK; Bano R; Seth SD
    Indian J Exp Biol; 2001 Oct; 39(10):955-61. PubMed ID: 11883519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic biomarkers and personalized medicine: application in cardiovascular pharmacology].
    Carrillo Norte JA
    Rev Enferm; 2013 Jan; 36(1):41-50. PubMed ID: 23427736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration--a key to success in the genetic dissection of complex diseases?
    Yagil Y; Yagil C
    Trends Cardiovasc Med; 2006 Feb; 16(2):35-8. PubMed ID: 16473759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular therapy and pharmacogenetics in 2007.
    Carlquist J
    Pharmacogenomics; 2007 Jan; 8(1):21-3. PubMed ID: 17187505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NCI All Ireland Cancer Conference.
    Johnston PG; Daly PA; Liu E
    Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospects for personalized cardiovascular medicine: the impact of genomics.
    Ginsburg GS; Donahue MP; Newby LK
    J Am Coll Cardiol; 2005 Nov; 46(9):1615-27. PubMed ID: 16256859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Genomics in cardiological clinical practice: from the individual response to drug therapy and monogenic cardiovascular disorders].
    Marziliano N; Orsini F; Veronese S; Colosimo A; Lauricella C; Motta V; Gambacorta M; Mauri F; Ardissino D; Merlini PA
    G Ital Cardiol (Rome); 2010 Oct; 11(10):767-8. PubMed ID: 21246778
    [No Abstract]   [Full Text] [Related]  

  • 18. [80 years' of internal medicine education at the medical school of the university in Belgrade (1922-2002)].
    Micić J; Micić D
    Srp Arh Celok Lek; 2003; 131(7-8):351-64. PubMed ID: 14692153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomics of cardiovascular disease.
    Manace LC; Godiwala TN; Babyatsky MW
    Mt Sinai J Med; 2009 Dec; 76(6):613-23. PubMed ID: 20014425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomics: the genomics of drug response.
    March R
    Yeast; 2000 Apr; 17(1):16-21. PubMed ID: 10797598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.